C74.1
Malignant neoplasm of medulla of adrenal gland
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the medulla of the adrenal gland, also known as adrenal medullary cancer, is a rare type of cancer that originates in the inner part of the adrenal glands. These small organs, located above each kidney, produce hormones that regulate vital body functions. When a malignant tumor develops in the adrenal medulla, it can disrupt hormone production and spread to other parts of the body. Understanding this condition is important for recognizing symptoms and seeking appropriate medical care.
Causes & Symptoms
Clinical Causes: Genetic mutations which may be inherited or acquired Family history of adrenal tumors or related genetic syndromes Exposure to certain environmental factors or toxins (though specific causes are not well understood) Associated conditions such as Multiple Endocrine Neoplasia (MEN) syndromes, particularly MEN2
Key Symptoms: High blood pressure Rapid heart rate (tachycardia) Sweating excessively Headaches Pale skin or unexplained weight loss Anxiety or feeling of nervousness Panic attacks Symptoms related to hormone imbalance like episodes of flushing or abnormal blood sugar levels
Diagnostic & Treatment
Diagnosis Path: The diagnosis of this cancer typically involves a combination of imaging tests and laboratory evaluations. These may include:
Treatment Protocols: Management of malignant neoplasm of the adrenal medulla generally requires a multidisciplinary approach. Common treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is C74.1 a billable ICD-10 code?
Yes, C74.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C74.1?
Clinical documentation must specify the nature of Malignant neoplasm of medulla of adrenal gland and any associated comorbidities for accurate reporting.
Cite this Clinical Reference